As a complex, multifactorial condition, inflammatory bowel disease (IBD) presents a challenge for research and pharmacological investigation. How do you select appropriate IBD animal models for precision research applications?
This webinar will review the latest research on IBD pathophysiology, progress in the development of animal models of the disease, and how these developments impact optimal study design in the pursuit of specific, hypothesis-driven research goals.
Dr. Philip Dubé studied gastrointestinal physiology at the University of Toronto, followed by IBD research fellowships at Vanderbilt University Medical Center and Children’s Hospital Los Angeles.
His research, focusing on growth factor and cytokine regulation of epithelial regeneration and T cell activation in mouse colitis models, has appeared in Gastroenterology and The Journal of Clinical Investigation.
© 2020 Taconic Biosciences, Inc. All rights reserved.